Expression of prothymosin alpha is correlated with development and progression in human prostate cancers

Prostate

Volumn 66, Issue 5, 2006, Pages 463-469

  Suzuki, Shugo ^a   Takahashi, Satoru ^a   Takahashi, Seishiro ^a   Takeshita, Kentaro ^a   Hikosaka, Atsuya ^a   Wakita, Toshiaki ^b   Nishiyama, Naoki ^c   Fujita, Tamio ^c   Okamura, Takehiko ^d   Shirai, Tomoyuki ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

^c Nagoya Memorial Hospital   (Japan)

^d Meijo Hospital   (Japan)

Author keywords

Cancer progression; Prostate cancer; Prothymosin alpha

Indexed keywords

PROTHYMOSIN ALPHA;

ARTICLE; CANCER CELL CULTURE; CANCER DIAGNOSIS; CANCER GROWTH; CANCER THERAPY; CARCINOGENESIS; CELL INVASION; CELL STRAIN; CELL STRAIN 22RV1; CELL STRAIN DU145; CELL STRAIN LNCAP; CELL STRAIN PC3; CONTROLLED STUDY; EPITHELIUM CELL; GENE SILENCING; GLEASON SCORE; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE CARCINOMA; PROSTATE EPITHELIUM; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN EXPRESSION; RNA INTERFERENCE;

AUTOPSY; CELL DIVISION; CELL LINE, TUMOR; DISEASE PROGRESSION; DNA PRIMERS; GENE DELETION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; PROTEIN PRECURSORS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THYMOSIN;

EID: 33645344343     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.20385     Document Type: Article

References (23)

1. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ. Cancer statistics, 2005. CA Cancer J Clin 2005;55(1):10-30.
2. Hsing AW, Tsao L, Devesa SS. International trends and patterns of prostate cancer incidence and mortality. Int J Cancer 2000;85(1):60-67.
3. Lalani el N, Laniado ME, Abel PD. Molecular and cellular biology of prostate cancer. Cancer Metastasis Rev 1997;16(1-2): 29-66.
4. Bonkhoff H, Remberger K. Morphogenetic concepts of normal and abnormal growth in the human prostate. Virchows Arch 1998;433(3):195-202.
5. Roudier MP, True LD, Higano CS, Vesselle H, Ellis W, Lange P, Vessella RL. Phenotypic heterogeneity of end-stage prostate carcinoma metastatic to bone. Hum Pathol 2003;34(7): 646-653.
6. Haritos AA, Goodall GJ, Horecker BL. Prothymosin alpha: Isolation and properties of the major immunoreactive form of thymosin alpha 1 in rat thymus. Proc Natl Acad Sci USA 1984;81(4):1008-1011.
7. Gomez-Marquez J, Segade F, Dosil M, Pichel JG, Bustelo XR, Freire M. The expression of prothymosin alpha gene in T lymphocytes and leukemic lymphoid cells is tied to lymphocyte proliferation. J Biol Chem 1989;264(15):8451-8454.
8. Eschenfeldt WH, Manrow RE, Krug MS, Berger SL. Isolation and partial sequencing of the human prothymosin alpha gene family. Evidence against export of the gene products. J Biol Chem 1989;264(13):7546-7555.
9. Pineiro A, Cordero OJ, Nogueira M. Fifteen years of prothymosin alpha: Contradictory past and new horizons. Peptides 2000;21(9):1433-1446.
10. Dominguez F, Magdalena C, Cancio E, Roson E, Paredes J, Loidi L, Zalvide J, Fraga M, Forteza J, Regueiro BJ. Tissue concentrations of prothymosiri alpha: A novel proliferation index of primary breast cancer. Eur J Cancer 1993;29A(6):893-897.
11. Tsitsilonis OE, Bekris E, Voutsas IF, Baxevanis CN, Markopoulos C, Papadopoulou SA, Kontzoglou K, Stoeva S, Gogas J, Voelter W, Papamichail M. The prognostic value of alpha-thymosins in breast cancer. Anticancer Res 1998;18(3A):1501-1508.
12. Magdalena C, Dominguez F, Loidi L, Puente JL. Tumour prothymosin alpha content, a potential prognostic marker for primary breast cancer. Br J Cancer 2000;82(3):584-590.
13. Mori M, Barnard GF, Staniunas RJ, Jessup JM, Steele GD Jr., Chen LB. Prothymosin-alpha mRNA expression correlates with that of c-myc in human colon cancer. Oncogene 1993;8(10):2821-2826.
14. Wu CG, Habib NA, Mitry RR, Reitsma PH, van Deventer SJ, Chamuleau RA. Overexpression of hepatic prothymosin alpha, a novel marker for human hepatocellular carcinoma. Br J Cancer 1997;76(9):1199-1204.
15. Sasaki H, Nonaka M, Fujii Y, Yamakawa Y, Fukai I, Kiriyama M, Sasaki M. Expression of the prothymosin-a gene as a prognostic factor in lung cancer. Surg Today 2001;31(10):936-938.
16. Hikosaka A, Asamoto M, Hokaiwado N, Kato K, Kuzutani K, Kohri K, Shirai T. Inhibitory effects of soy isoflavones on rat prostate carcinogenesis induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Carcinogenesis 2004;25(3):381-387.
17. Saito K, Oku T, Ata N, Miyashiro H, Hattori M, Saiki I. A modified and convenient method for assessing tumor cell invasion and migration and its application to screening for inhibitors. Biol Pharm Bull 1997;20(4):345-348.
18. Karetsou Z, Sandaltzopoulos R, Frangou-Lazaridis M, Lai CY, Tsolas O, Becker PB, Papamarcaki T. Prothymosin alpha modulates the interaction of histone H1 with chromatin. Nucleic Acids Res 1998;26(13):3111-3118.
19. Papamarcaki T, Tsolas O. Prothymosin alpha binds to histone H1 in vitro. FEBS Lett 1994;345(1):71-75.
20. Karetsou Z, Martic G, Tavoulari S, Christoforidis S, Wilm M, Gruss C, Papamarcaki T. Prothymosin alpha associates with the oncoprotein SET and is involved in chromatin decondensation. FEBS Lett 2004;577(3):496-500.
21. Karetsou Z, Kretsovali A, Murphy C, Tsolas O, Papamarcaki T. Prothymosin alpha interacts with the CREB-binding protein and potentiates transcription. EMBO Rep 2002;3(4):361-366.
22. Martini PG, Delage-Mourroux R, Kraichely DM, Katzenellenbogen BS. Prothymosin alpha selectively enhances estrogen receptor transcriptional activity by interacting with a repressor of estrogen receptor activity. Mol Cell Biol 2000;20(17):6224-6232.
23. Bianco NR, Montano MM. Regulation of prothymosin alpha by estrogen receptor alpha: Molecular mechanisms and relevance in estrogen-mediated breast cell growth. Oncogene 2002;21(34): 5233-5244.